Literature DB >> 10893382

The diagnosis and management of hypertensive crises.

J Varon1, P E Marik.   

Abstract

Severe hypertension is a common clinical problem in the United States, encountered in various clinical settings. Although various terms have been applied to severe hypertension, such as hypertensive crises, emergencies, or urgencies, they are all characterized by acute elevations in BP that may be associated with end-organ damage (hypertensive crisis). The immediate reduction of BP is only required in patients with acute end-organ damage. Hypertension associated with cerebral infarction or intracerebral hemorrhage only rarely requires treatment. While nitroprusside is commonly used to treat severe hypertension, it is an extremely toxic drug that should only be used in rare circumstances. Furthermore, the short-acting calcium channel blocker nifedipine is associated with significant morbidity and should be avoided. Today, a wide range of pharmacologic alternatives are available to the practitioner to control severe hypertension. This article reviews some of the current concepts and common misconceptions in the management of patients with acutely elevated BP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10893382     DOI: 10.1378/chest.118.1.214

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  41 in total

1.  Managing hypertensive emergencies in the ED.

Authors:  Lyle Thomas
Journal:  Can Fam Physician       Date:  2011-10       Impact factor: 3.275

Review 2.  Muscle KATP channels: recent insights to energy sensing and myoprotection.

Authors:  Thomas P Flagg; Decha Enkvetchakul; Joseph C Koster; Colin G Nichols
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

3.  Cardiovascular reactivity to mental stress is not affected by alpha2-adrenoreceptor activation or inhibition.

Authors:  Christine Philippsen; Melanie Hahn; Lars Schwabe; Steffen Richter; Jürgen Drewe; Hartmut Schachinger
Journal:  Psychopharmacology (Berl)       Date:  2006-11-17       Impact factor: 4.530

Review 4.  Drugs for the perioperative control of hypertension: current issues and future directions.

Authors:  Robert Feneck
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Thirty-Day Readmissions After Hospitalization for Hypertensive Emergency.

Authors:  Nilay Kumar; Shawn Simek; Neetika Garg; Muthiah Vaduganathan; Farah Kaiksow; James H Stein; Gregg C Fonarow; Ambarish Pandey; Deepak L Bhatt
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

Review 6.  Drug treatment of hypertensive crisis in children.

Authors:  Christopher A Thomas
Journal:  Paediatr Drugs       Date:  2011-10-01       Impact factor: 3.022

7.  Recognition and management of complications during moderate and deep sedation. Part 2: cardiovascular considerations.

Authors:  Daniel E Becker; Daniel A Haas
Journal:  Anesth Prog       Date:  2011

8.  Management of complications during moderate and deep sedation: respiratory and cardiovascular considerations.

Authors:  Daniel E Becker; Daniel A Haas
Journal:  Anesth Prog       Date:  2007

Review 9.  Management of hypertension emergencies.

Authors:  William J Elliott
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

10.  Predictors of hemodynamic instability during surgery for pheochromocytoma.

Authors:  Colleen M Kiernan; Liping Du; Xi Chen; James T Broome; Chanjuan Shi; Mary F Peters; Carmen C Solorzano
Journal:  Ann Surg Oncol       Date:  2014-06-18       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.